AngioTarget         Angiostatic strategies for cancer therapy                  

 

 

Home

 

The Company

 

Technology

 

Publications

 

News

 

Links

 

Contact

 

 

 

 

 

 

 

 

 

 

 

 

 

News

 

June 2016 - AngioTarget receives funding from the EU Horizon 2020. Call H2020-SMEINST-1-2015. Project 717287 (ANGIO-IMAGE).

January 2014 – AngioTarget receives Proof of Concept grant from the VUMC TTO office for the development of its first vaccine AngioT1®

December 2013 - AngioTarget signs collaboration and license agreement with VUMC

          

    

                                 

    

 

 

   

© AngioVacs BV